Pharmacological reduction of mucosal but not neuronal serotonin opposes inflammation in mouse intestine.
about
The Neuromodulation of the Intestinal Immune System and Its Relevance in Inflammatory Bowel DiseaseSerotonin transporter variant drives preventable gastrointestinal abnormalities in development and function.The serotonin system in autism spectrum disorder: From biomarker to animal modelsIdentification of a Novel Allosteric Inhibitory Site on Tryptophan Hydroxylase 1 Enabling Unprecedented Selectivity Over all Related HydroxylasesSerotonergic Mechanisms Regulating the GI Tract: Experimental Evidence and Therapeutic RelevanceAn integrative view of microbiome-host interactions in inflammatory bowel diseasesAssociation of Serotonin Transporter Promoter Polymorphism (5HTTLPR) with Microscopic Colitis and Ulcerative Colitis: Time to Be AsSERTive?Serotonin and colonic motility.RGS proteins as targets in the treatment of intestinal inflammation and visceral pain: New insights and future perspectivesConstitutively Elevated Blood Serotonin Is Associated with Bone Loss and Type 2 Diabetes in Rats.Dual Role of Endogenous Serotonin in 2,4,6-Trinitrobenzene Sulfonic Acid-Induced Colitis.The injury of serotonin on intestinal epithelium cell renewal of weaned diarrhoea mice.Role of transient receptor potential channels in intestinal inflammation and visceral pain: novel targets in inflammatory bowel diseases.Intestinal barrier homeostasis in inflammatory bowel disease.5-HT7 receptor signaling: improved therapeutic strategy in gut disordersUnderlying molecular and cellular mechanisms in childhood irritable bowel syndromeEnteric Serotonin and Oxytocin: Endogenous Regulation of Severity in a Murine Model of Necrotizing Enterocolitis.Novel investigational drugs for constipation-predominant irritable bowel syndrome: a review.Listeria monocytogenes Inhibits Serotonin Transporter in Human Intestinal Caco-2 Cells.Inhibition of Peripheral Synthesis of Serotonin as a New Target in Neuroendocrine Tumors.Enteric Neuronal Regulation of Intestinal Inflammation.The TNF-α antagonist etanercept reverses age-related decreases in colonic SERT expression and faecal output in mice.Telotristat ethyl: a new option for the management of carcinoid syndrome.Tyrosine and tryptophan hydroxylases as therapeutic targets in human disease.A role for the serotonin reuptake transporter in the brain and intestinal features of autism spectrum disorders and developmental antidepressant exposure.Non-conventional features of peripheral serotonin signalling - the gut and beyond.Review article: the many potential roles of intestinal serotonin (5-hydroxytryptamine, 5-HT) signalling in inflammatory bowel disease.Serotonin biosynthesis as a predictive marker of serotonin pharmacodynamics and disease-induced dysregulation.5-HT3 receptors promote colonic inflammation via activation of substance P/neurokinin-1 receptors in dextran sulphate sodium-induced murine colitis.Anticolitis activity of Chinese herbal formula yupingfeng powder via regulating colonic enterochromaffin cells and serotonin.Sodium channel NaV1.3 is important for enterochromaffin cell excitability and serotonin release.Analysis of enteroendocrine cell populations in the human colon.Selective inhibition of mucosal serotonin as treatment for IBD?Impact of the Gut Microbiota on Intestinal Immunity Mediated by Tryptophan Metabolism.Colitis induces enteric neurogenesis through a 5-HT4-dependent mechanism.A sexually dimorphic effect of cholera toxin: rapid changes in colonic motility mediated via a 5-HT3 receptor-dependent pathway in female C57Bl/6 mice.Blocking peripheral serotonin synthesis by telotristat etiprate (LX1032/LX1606) reduces severity of both chemical- and infection-induced intestinal inflammation.Developments in the treatment of carcinoid syndrome - impact of telotristat.Enterochromaffin 5-HT cells - A major target for GLP-1 and gut microbial metabolites.Gut microbiota regulates maturation of the adult enteric nervous system via enteric serotonin networks.
P2860
Q26774660-00992D78-540E-4CC3-956C-17C9341DDB13Q27329816-93F2CDB5-C0C8-4EDC-B2CD-D15EF165167DQ28391614-8AF66BF0-CCF0-46A1-824D-13EBF155A226Q33639498-FE11702E-6259-483B-91C6-A19EFEE012F6Q33926234-E9E98243-616D-40F3-AA1E-125B4892D94AQ35631737-0539FF96-D285-43C7-935E-702ACC20DAADQ35694154-B90298B0-B0E3-48C4-8F6A-C3BB4B15CE08Q35769302-54543D2B-485A-404A-94FE-569290175058Q35906057-C763EE3F-6C3D-410A-974D-ADFCAA52D524Q35933172-611EBB4C-1699-4FB6-8453-0E0664A8ABC7Q36713342-E7EA0807-161D-473C-9B3A-0B75729B971BQ37738526-E80B4084-C929-4B79-AB68-629B5EED7149Q38273302-89F706F2-C3DB-4615-9C36-ED74531CD50EQ38293757-39EF8A13-324A-4448-A942-A6C3168CAA39Q38310117-A26C6525-60FB-4B3C-B3DD-2AB590A9B42BQ38515695-EFEE0644-DC36-47CB-865F-B2598BACCB29Q38642487-BC5814D1-D9BA-4C75-867D-70B4E35C83D5Q38696256-32609633-68AD-4DEC-9F39-8556DA835D2AQ38753965-4C84F62E-CF23-4EC0-AA42-229052496937Q38815549-904731BE-C9E0-4E15-AA02-2CB28A52F939Q38838568-DD3763BE-581C-42D0-9735-95EBCC1C4446Q38960868-F7310730-3764-4CAC-9750-C5E72A8A57D8Q39000212-1664BDF6-2C6B-4BF2-ABC0-16432C49D6FFQ39038494-889F273D-5676-42CC-9377-DD092470A440Q39141290-12D53C55-C6C9-49C2-8DA2-0012E4A28A56Q39294424-4D6C6CD9-F586-4893-BB9C-FC237F0F286CQ39453973-2043AC71-9C09-431B-97AC-71D43DFF5935Q42053148-58D8FCAF-3E4C-45B4-A883-411DA15F55C0Q42244233-DC4C4DA1-FD42-41CB-86C3-554BF7B2D1F1Q42836689-B6AFA0AA-6EFA-4C20-B36D-087327C73B77Q45866966-861B8833-D500-4F38-AF93-83425B011F8EQ46460025-BE868C11-0D12-4B2C-A4C6-300F2E1507CFQ46567489-5DFB6055-94E1-4D53-A629-6E08C8478CB1Q50223024-994FA4EC-BDBD-4C02-8609-CD415C94EA96Q50597477-5BF71D6F-D1EB-4CBC-AD34-10F7A6DAF9DDQ50918442-DBB5354A-1794-4CFD-ABE8-C67A66B0D941Q50952188-023B3683-E879-4ED9-B94F-B69173A33482Q52674898-6B54A83D-9F72-4F7E-BE57-FC045BB2E2F3Q55240665-6ED7D1F3-F421-4A47-9817-233475BDC56AQ55290924-DACF71BD-BDE9-48DB-9B26-8E4CCFC657F6
P2860
Pharmacological reduction of mucosal but not neuronal serotonin opposes inflammation in mouse intestine.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Pharmacological reduction of m ...... flammation in mouse intestine.
@ast
Pharmacological reduction of m ...... flammation in mouse intestine.
@en
type
label
Pharmacological reduction of m ...... flammation in mouse intestine.
@ast
Pharmacological reduction of m ...... flammation in mouse intestine.
@en
prefLabel
Pharmacological reduction of m ...... flammation in mouse intestine.
@ast
Pharmacological reduction of m ...... flammation in mouse intestine.
@en
P2093
P2860
P1433
P1476
Pharmacological reduction of m ...... flammation in mouse intestine.
@en
P2093
Alexander Diacou
Brian Zambrowicz
Kanchan G Jhaver
Kara Gross Margolis
Korey Stevanovic
Michael D Gershon
Qi Melissa Yang
Tamas Oravecz
Zhishan Li
P2860
P304
P356
10.1136/GUTJNL-2013-304901
P407
P577
2013-06-07T00:00:00Z